7th February 2008

Save time on your product and fund research

UK advisers spend around 40% less time with their clients than their Australian counterparts according to research. Outsourcing product and fund research is one way to redress this imbalance and allow advisers to spend more time with clients gaining more business.

Now Panacea members can get access to the new Rayner Spencer Mills website which has been launched to deliver recommended product and fund lists to small and medium sized IFA firms in the UK.

And RSM is offering all Panacea firms free access for the first month once they agree to subscribe to the service.

Just contact enquiries@rsmgroup.co.uk for more details of the offer and how to get access.

RSM currently construct recommended product and fund lists for a number of large IFA firms and using the same quantitative and qualitative measures we have launched an online service aimed specifically at the small to medium sized IFA sector.

Combining our research approach with the new web-based delivery allows us to provide fully researched product and fund lists for small and medium sized Advisory firms who may not have previously considered outsourcing.

This important development for the Advisory sector will help firms deliver on a number of areas under the FSA’s Treating Customers Fairly initiative by providing a robust and consistent approach to product and fund research. This approach improves the consistency of advice and frees the adviser to spend more time developing their relationship with clients.

The service is competitively priced at just £99.00 per Advisory firm plus £10 per user (plus VAT) and is charged on a monthly basis to help with budgeting. Individual user IDs and passwords will be provided once a firm subscribes to the service, which is delivered on a secure website meeting all the latest security protocols. Individual product and fund factsheets are also available on the site to aid the selection and suitability process.

As an IFA why not chose another totally independent firm that is 100% focused on research – we wait to hear from you!